SRTR-Published Risk: Long-Wait + Medicaid States
The SRTR (Scientific Registry of Transplant Recipients) publishes program-level outcome data, including waitlist mortality rates, time-to-transplant distributions, and patients-by-payer breakdowns. From that data, certain geographic patterns emerge:
The long-wait + Medicaid risk pattern
Some states have only one or two transplant centers, those centers have structurally long waitlists, and their Medicaid acceptance pathways are narrower than their commercial-insurance pathways. Patients in those states who depend on Medicaid face elevated waitlist mortality unless they dual-list out of state.
Why this matters:
- The pattern is not a moral failure — it reflects donor supply geometry, payer mix, and listing capacity.
- It is, however, an actionable risk: patients can dual-list at a center in a different OPTN region with shorter waits or broader Medicaid acceptance.
- Dual-listing requires a second evaluation, insurance pre-authorization, and travel planning. None of it is easy. All of it is doable.
What to ask your local center:
- "What is the median time-to-transplant for Medicaid patients at this program over the past 24 months?"
- "How many of your transplants in the past year were in Medicaid recipients?"
- "Do you support patients who choose to dual-list at another center?"
What to ask a candidate dual-list center:
- "Do you accept out-of-state Medicaid? Through what mechanism?"
- "What is your program's evaluation timeline for an out-of-state patient?"
- "What does the first 90 days post-transplant look like for an out-of-state Medicaid patient?"
The SRTR publishes its data publicly at srtr.org. Ask your hepatologist or the patient advocate to walk through the relevant CSR (Center-Specific Report) with you.
Educational only — clinician review pending. Not medical advice. Your transplant team has the final word.